By Josh White
Date: Wednesday 17 Sep 2025
(Sharecast News) - Hikma Pharmaceuticals and Kier Group both reported director share dealings on Wednesday.
| Holding(s) in Company | 05-Nov-2025 | 11:24 | RNS |
| Transaction in Own Shares | 05-Nov-2025 | 07:00 | RNS |
| Director/PDMR Shareholding | 04-Nov-2025 | 12:15 | RNS |
| Transaction in Own Shares | 04-Nov-2025 | 07:00 | RNS |
| Holding(s) in Company | 03-Nov-2025 | 16:50 | RNS |
| Questor:Kier Group | 01-Dec-2011 | Telegraph |
| Investment Column:Kier | 16-Sep-2011 | The Independent |
| Questor:Kier Group | 24-Jun-2011 | Telegraph |
| Questor : Kier Group | 25-Nov-2010 | Telegraph |
| Investment Column:Kier | 23-Nov-2010 | The Independent |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 213.50p |
| Change Today | 0.50p |
| % Change | 0.23 % |
| 52 Week High | 231.50 |
| 52 Week Low | 115.20 |
| Volume | 702,291 |
| Shares Issued | 444.92m |
| Market Cap | £949.91m |
| Beta | 1.32 |
| RiskGrade | 260 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 1 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 7 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 30-Oct-25 | 24-Apr-25 |
| Paid | 03-Dec-25 | 02-Jun-25 |
| Amount | 5.20p | 2.00p |
| Time | Volume / Share Price |
| 16:35 | 2,389 @ 213.50p |
| 16:35 | 216,924 @ 213.50p |
| 16:35 | 2,752 @ 213.50p |
| 16:35 | 1,331 @ 213.50p |
| 16:35 | 803 @ 213.50p |
| Chair | Matthew Lester |
| CEO | Stuart Togwell |
You are here: research